Abstract
The increasing incidence of obesity, leading to metabolic complications is now recognized as a major public-health problem. Insulin resistance is a central abnormality of the metabolic syndrome, or syndrome X, originally hypothesized by Reaven Insulin resistance is more strongly linked to intra abdominal fat than to fat in other depots. Adipose tissue secretes numerous factors (adipokines) known to markedly influence lipid and glucose/insulin metabolism, oxidative stress, and cardiovascular integrity. Some of these adipokines have been shown to directly or indirectly affect insulin sensitivity through modulation of insulin signaling and the molecules involved in glucose and lipid metabolism. A pilot study was conducted with 80 healthy subjects who were non diabetic, non hypertensive and having no family history of hypertension, the aim was to evaluate the correlation of adiponectin and leptin levels with obesity and insulin resistance markers in healthy north Indian adult population. Serum leptin, adiponectin and insulin was estimated by sandwich ELISA method. In our study, Leptin correlated significantly with BMI (P value of 0.0000), WC (P value = 0.007), and HC (P value = 0.000). leptin showed significant positive correlation with fasting insulin (P value 0.002), post prandial insulin (P value = 0.000) and HOMA-IR (P value = 0.002). Adiponectin showed significant positive correlation with triglycerides (P value = 0.038), strong negative correlation with HDL-cholesterol (P value = 0.017). Serum concentrations of leptin are associated with central body fat distribution. Insulin resistance and adiponectin is associated with dyslipidemia and these all disorders may ultimately lead to metabolic syndrome.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–607.
Stefan N, Stumvoll M. Adiponectin: its role in metabolism and beyond. Horm Metab Res. 2002;43:469–74.
Diez JJ, Iglesias P. Role of novel adipocyte derived hormone adiponectin in human disease. Eur J Clin Endocrinol. 2003;148:293–300.
Lowell BB. PPARγ: an essential regulator of adipogenesis and modulator of fat cell function. Cell. 1999;99:239–42.
Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. ACRP30/adiponectin; adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002;13:84–9.
Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R. Molecular mechanisms of insulin resistance and obesity. Exp Biol Med. 2003;228:1111–7.
Yamauchi T, Kamon J. Adiponectin stimulates glucose utilization and fatty acid oxidation by activating AMP-kinase. Nat Med. 2002;8:1288–95.
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–32.
Ahima RS, Prabakaran D, Flier JS. Leptin. Annu Rev Physiol. 2000;62:413–37.
Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, et al. Leptin—replacement therapy for lipodystrophy. N Engl J Med. 2002;346:570–8.
Vikram NK, Misra A, Pandey RM, Dwivedi M, Luthra K. Adiponectin, insulin resistance, and C-reactive protein in postpubertal Asian Indian adolescents. Metabolism. 2004;53:1336–41.
Halleux CM, Takahashi M, Delporte ML, Detry R, Funahashi T, Matsuzawa Y, et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun. 2001;288:1102–7.
Statnick MA, Beavers LS, Conner LJ, Corominola H, Johnson D, Hammond CD, et al. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res. 2001;1:81–8.
Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol. 2002;147:173–80.
Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930–5.
Yamamota Y, Hiroshi H, Saito I, Tomita M, Taniyama M, Matsubara K, et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci. 2002;103:137–42.
Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20:1595–9.
Minocci A, Savia G, Lucantoni R, Berselli ME, Tagliaferri M, Calò G, et al. Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes Relat Metab Disord. 2000;24:1139–44.
De Courten M, Zimmet P, Hodge A, Collins V, Nicolson M, Staten M, et al. Hyperleptenemia; the missing link in metabolic syndrome. Diabeties Med. 1997;14:200–8.
Walder K, Fillips A, Clark S. Leptin inhibits insulin binding in isolated rat adipocytes. J Endocrinol. 1997;155:R5–7.
Mantzoros CS, Qu D, Frederich RC, Susulic VS, Lowell BB, Maratos FE, et al. Activation of β-3 adrenergic receptors suppresses leptin expression in mice. Diabetes. 1996;45:909–14.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yadav, A., jyoti, P., Jain, S.K. et al. Correlation of Adiponectin and Leptin with Insulin Resistance: A Pilot Study in Healthy North Indian Population. Ind J Clin Biochem 26, 193–196 (2011). https://doi.org/10.1007/s12291-011-0119-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-011-0119-1